1570262-20-2

Basic information

• Product Name: morpholino-(5-nitro-[1,1'-biphenyl]-3-yl)methanone
• Synonyms: morpholino-(5-nitro-[1,1'-biphenyl]-3-yl)methanone
• CAS NO: 1570262-20-2
• Molecular Weight: 312.325
• Mol File: 1570262-20-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: morpholino-(5-nitro-[1,1'-biphenyl]-3-yl)methanone(CAS DataBase Reference)
• NIST Chemistry Reference: morpholino-(5-nitro-[1,1'-biphenyl]-3-yl)methanone(1570262-20-2)
• EPA Substance Registry System: morpholino-(5-nitro-[1,1'-biphenyl]-3-yl)methanone(1570262-20-2)

Safety Data

• Hazardous Substances Data: 1570262-20-2(Hazardous Substances Data)

Upstream product

• 117342-20-8 (3-(methoxycarbonyl)-5-nitrophenyl)boronic acid 
• 108-86-1 bromobenzene 
• 110-91-8 morpholine 
• 188355-96-6 5-nitro-[1,1'-biphenyl]-3-carboxylic acid 
• 6307-83-1 3-bromo-5-nitro-benzoic acid 
• 941294-19-5 (3-bromo-5-nitrophenyl)(morpholin-4-yl)methanone 
• 98-80-6 phenylboronic acid 

Downstream Products

• 1570262-22-4 (5-amino-[1,1'-biphenyl]-3-yl)(morpholino)methanone 
• 1570255-74-1 morpholin-4-yl(5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}biphenyl-3-yl)methanone 

Relevant articles and documents

Kinase inhibitors (by machine translation)

The present invention relates to certain 4 - (substituted anilino) -2 - (substituted piperi -1 -yl) pyrimidine -5 - carboxamide compounds useful for the treatment or prevention of diseases or medical conditions mediated by signal transduction of CaMMK1 isotype. For example, such compounds and salts thereof may be used to treat or prevent a variety of different cancers. Diseases (including 2 diabetes) and/or immune-mediated diseases. (by machine translation)